APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buprenorphine Transdermal Patches

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Buprenorphine Transdermal Patches Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchBuprenorphine Transdermal Patches Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Buprenorphine Transdermal Patches Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Buprenorphine Transdermal Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buprenorphine Transdermal Patches Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Buprenorphine Transdermal Patches Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Buprenorphine Transdermal Patches market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Buprenorphine Transdermal Patches is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Buprenorphine Transdermal Patches include Luye Pharma, PurduePharma and Grunenthal, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Buprenorphine Transdermal Patches, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Buprenorphine Transdermal Patches, also provides the sales of main regions and countries. Of the upcoming market potential for Buprenorphine Transdermal Patches, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Buprenorphine Transdermal Patches sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Buprenorphine Transdermal Patches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Buprenorphine Transdermal Patches sales, projected growth trends, production technology, application and end-user industry.

Buprenorphine Transdermal Patches Segment by Company

Luye Pharma

PurduePharma

Grunenthal

Buprenorphine Transdermal Patches Segment by Type

10mcg/h

15 mcg/h

20 mcg/h

5mcg/h

7.5mcg/h

Buprenorphine Transdermal Patches Segment by Application

Relieve Cancer Pain

Other

Buprenorphine Transdermal Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Transdermal Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Transdermal Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Transdermal Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Buprenorphine Transdermal Patches in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Buprenorphine Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Buprenorphine Transdermal Patches sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mcg/h Major Manufacturers Table 3. 15 mcg/h Major Manufacturers Table 4. 20 mcg/h Major Manufacturers Table 5. 5mcg/h Major Manufacturers Table 6. 7.5mcg/h Major Manufacturers Table 7. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Relieve Cancer Pain Major Manufacturers Table 9. Other Major Manufacturers Table 10. Buprenorphine Transdermal Patches Industry Trends Table 11. Buprenorphine Transdermal Patches Industry Drivers Table 12. Buprenorphine Transdermal Patches Industry Opportunities and Challenges Table 13. Buprenorphine Transdermal Patches Industry Restraints Table 14. Global Buprenorphine Transdermal Patches Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Buprenorphine Transdermal Patches Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Buprenorphine Transdermal Patches Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2021-2026) Table 18. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2027-2032) Table 19. Global Buprenorphine Transdermal Patches Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (k units) Table 21. Global Buprenorphine Transdermal Patches Sales by Region (2027-2032) & (k units) Table 22. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2021-2026) Table 23. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2027-2032) Table 24. Global Buprenorphine Transdermal Patches Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Buprenorphine Transdermal Patches Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Buprenorphine Transdermal Patches Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturers (2021-2026) Table 28. Global Buprenorphine Transdermal Patches Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Buprenorphine Transdermal Patches Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Buprenorphine Transdermal Patches Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Buprenorphine Transdermal Patches Manufacturers, Product Type & Application Table 32. Global Buprenorphine Transdermal Patches Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Buprenorphine Transdermal Patches by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Buprenorphine Transdermal Patches Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2026) Table 39. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2027-2032) Table 40. Global Buprenorphine Transdermal Patches Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 42. Global Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 43. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2026) Table 44. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2027-2032) Table 45. Global Buprenorphine Transdermal Patches Price by Type (2021-2026) & (US$/unit) Table 46. Global Buprenorphine Transdermal Patches Price by Type (2027-2032) & (US$/unit) Table 47. Global Buprenorphine Transdermal Patches Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2026) Table 51. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2027-2032) Table 52. Global Buprenorphine Transdermal Patches Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 54. Global Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 55. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2026) Table 56. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2027-2032) Table 57. Global Buprenorphine Transdermal Patches Price by Application (2021-2026) & (US$/unit) Table 58. Global Buprenorphine Transdermal Patches Price by Application (2027-2032) & (US$/unit) Table 59. Luye Pharma Company Information Table 60. Luye Pharma Business Overview Table 61. Luye Pharma Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Luye Pharma Buprenorphine Transdermal Patches Product Portfolio Table 63. Luye Pharma Recent Development Table 64. PurduePharma Company Information Table 65. PurduePharma Business Overview Table 66. PurduePharma Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. PurduePharma Buprenorphine Transdermal Patches Product Portfolio Table 68. PurduePharma Recent Development Table 69. Grunenthal Company Information Table 70. Grunenthal Business Overview Table 71. Grunenthal Buprenorphine Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Grunenthal Buprenorphine Transdermal Patches Product Portfolio Table 73. Grunenthal Recent Development Table 74. North America Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 77. North America Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 78. North America Buprenorphine Transdermal Patches Sales Price by Type (2021-2026) & (US$/unit) Table 79. North America Buprenorphine Transdermal Patches Sales Price by Type (2027-2032) & (US$/unit) Table 80. North America Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 83. North America Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 84. North America Buprenorphine Transdermal Patches Sales Price by Application (2021-2026) & (US$/unit) Table 85. North America Buprenorphine Transdermal Patches Sales Price by Application (2027-2032) & (US$/unit) Table 86. North America Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 90. North America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 91. North America Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 92. North America Buprenorphine Transdermal Patches Sales Price by Country (2021-2026) & (US$/unit) Table 93. North America Buprenorphine Transdermal Patches Sales Price by Country (2027-2032) & (US$/unit) Table 94. United States Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 95. Canada Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 96. Mexico Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 97. Europe Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 100. Europe Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 101. Europe Buprenorphine Transdermal Patches Sales Price by Type (2021-2026) & (US$/unit) Table 102. Europe Buprenorphine Transdermal Patches Sales Price by Type (2027-2032) & (US$/unit) Table 103. Europe Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 106. Europe Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 107. Europe Buprenorphine Transdermal Patches Sales Price by Application (2021-2026) & (US$/unit) Table 108. Europe Buprenorphine Transdermal Patches Sales Price by Application (2027-2032) & (US$/unit) Table 109. Europe Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 113. Europe Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 114. Europe Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 115. Europe Buprenorphine Transdermal Patches Sales Price by Country (2021-2026) & (US$/unit) Table 116. Europe Buprenorphine Transdermal Patches Sales Price by Country (2027-2032) & (US$/unit) Table 117. Germany Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 118. France Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 119. U.K. Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 120. Italy Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 121. Russia Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 122. Spain Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 124. Switzerland Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 125. Sweden Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 126. Poland Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 127. China Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 128. China Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 129. China Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 130. China Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 131. China Buprenorphine Transdermal Patches Sales Price by Type (2021-2026) & (US$/unit) Table 132. China Buprenorphine Transdermal Patches Sales Price by Type (2027-2032) & (US$/unit) Table 133. China Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 134. China Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 135. China Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 136. China Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 137. China Buprenorphine Transdermal Patches Sales Price by Application (2021-2026) & (US$/unit) Table 138. China Buprenorphine Transdermal Patches Sales Price by Application (2027-2032) & (US$/unit) Table 139. Asia Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 142. Asia Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 143. Asia Buprenorphine Transdermal Patches Sales Price by Type (2021-2026) & (US$/unit) Table 144. Asia Buprenorphine Transdermal Patches Sales Price by Type (2027-2032) & (US$/unit) Table 145. Asia Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 148. Asia Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 149. Asia Buprenorphine Transdermal Patches Sales Price by Application (2021-2026) & (US$/unit) Table 150. Asia Buprenorphine Transdermal Patches Sales Price by Application (2027-2032) & (US$/unit) Table 151. Asia Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 155. Asia Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 156. Asia Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 157. Asia Buprenorphine Transdermal Patches Sales Price by Country (2021-2026) & (US$/unit) Table 158. Asia Buprenorphine Transdermal Patches Sales Price by Country (2027-2032) & (US$/unit) Table 159. Japan Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 160. South Korea Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 161. India Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 162. Australia Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 163. Taiwan Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Buprenorphine Transdermal Patches Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (k units) Table 168. SAMEA Buprenorphine Transdermal Patches Sales by Type (2027-2032) & (k units) Table 169. SAMEA Buprenorphine Transdermal Patches Sales Price by Type (2021-2026) & (US$/unit) Table 170. SAMEA Buprenorphine Transdermal Patches Sales Price by Type (2027-2032) & (US$/unit) Table 171. SAMEA Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Buprenorphine Transdermal Patches Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (k units) Table 174. SAMEA Buprenorphine Transdermal Patches Sales by Application (2027-2032) & (k units) Table 175. SAMEA Buprenorphine Transdermal Patches Sales Price by Application (2021-2026) & (US$/unit) Table 176. SAMEA Buprenorphine Transdermal Patches Sales Price by Application (2027-2032) & (US$/unit) Table 177. SAMEA Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 181. SAMEA Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (k units) Table 182. SAMEA Buprenorphine Transdermal Patches Sales by Country (2027-2032) & (k units) Table 183. SAMEA Buprenorphine Transdermal Patches Sales Price by Country (2021-2026) & (US$/unit) Table 184. SAMEA Buprenorphine Transdermal Patches Sales Price by Country (2027-2032) & (US$/unit) Table 185. Brazil Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 186. Argentina Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 187. Chile Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 188. Colombia Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 189. Peru Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 191. Israel Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 192. UAE Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 193. Turkey Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 194. Iran Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 195. Egypt Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Buprenorphine Transdermal Patches Distributors List Table 199. Buprenorphine Transdermal Patches Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Buprenorphine Transdermal Patches Image Figure 2. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buprenorphine Transdermal Patches Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mcg/h Image Figure 5. 15 mcg/h Image Figure 6. 20 mcg/h Image Figure 7. 5mcg/h Image Figure 8. 7.5mcg/h Image Figure 9. Global Buprenorphine Transdermal Patches Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Buprenorphine Transdermal Patches Market Size Share 2021 VS 2025 VS 2032 Figure 11. Relieve Cancer Pain Image Figure 12. Other Image Figure 13. Global Buprenorphine Transdermal Patches Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Buprenorphine Transdermal Patches Revenue (2021-2032) & (US$ Million) Figure 15. Global Buprenorphine Transdermal Patches Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Buprenorphine Transdermal Patches Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2021-2032) Figure 18. Global Buprenorphine Transdermal Patches Sales (2021-2032) & (k units) Figure 19. Global Buprenorphine Transdermal Patches Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Buprenorphine Transdermal Patches Sales YoY (2021-2032) & (k units) Figure 22. Europe Buprenorphine Transdermal Patches Sales YoY (2021-2032) & (k units) Figure 23. China Buprenorphine Transdermal Patches Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Buprenorphine Transdermal Patches Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Buprenorphine Transdermal Patches Sales YoY (2021-2032) & (k units) Figure 26. Global Buprenorphine Transdermal Patches Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Buprenorphine Transdermal Patches Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Buprenorphine Transdermal Patches Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Buprenorphine Transdermal Patches Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2032) Figure 32. Global Buprenorphine Transdermal Patches Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Buprenorphine Transdermal Patches Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2032) Figure 35. Global Buprenorphine Transdermal Patches Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Buprenorphine Transdermal Patches Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2032) Figure 38. Global Buprenorphine Transdermal Patches Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Buprenorphine Transdermal Patches Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2032) Figure 41. North America Buprenorphine Transdermal Patches Revenue Share by Type (2021-2032) Figure 42. North America Buprenorphine Transdermal Patches Sales Share by Type (2021-2032) Figure 43. North America Buprenorphine Transdermal Patches Revenue Share by Application (2021-2032) Figure 44. North America Buprenorphine Transdermal Patches Sales Share by Application (2021-2032) Figure 45. North America Buprenorphine Transdermal Patches Revenue Share by Country (2021-2032) Figure 46. North America Buprenorphine Transdermal Patches Sales Share by Country (2021-2032) Figure 47. Europe Buprenorphine Transdermal Patches Revenue Share by Type (2021-2032) Figure 48. Europe Buprenorphine Transdermal Patches Sales Share by Type (2021-2032) Figure 49. Europe Buprenorphine Transdermal Patches Revenue Share by Application (2021-2032) Figure 50. Europe Buprenorphine Transdermal Patches Sales Share by Application (2021-2032) Figure 51. Europe Buprenorphine Transdermal Patches Revenue Share by Country (2021-2032) Figure 52. Europe Buprenorphine Transdermal Patches Sales Share by Country (2021-2032) Figure 53. China Buprenorphine Transdermal Patches Revenue Share by Type (2021-2032) Figure 54. China Buprenorphine Transdermal Patches Sales Share by Type (2021-2032) Figure 55. China Buprenorphine Transdermal Patches Revenue Share by Application (2021-2032) Figure 56. China Buprenorphine Transdermal Patches Sales Share by Application (2021-2032) Figure 57. Asia Buprenorphine Transdermal Patches Revenue Share by Type (2021-2032) Figure 58. Asia Buprenorphine Transdermal Patches Sales Share by Type (2021-2032) Figure 59. Asia Buprenorphine Transdermal Patches Revenue Share by Application (2021-2032) Figure 60. Asia Buprenorphine Transdermal Patches Sales Share by Application (2021-2032) Figure 61. Asia Buprenorphine Transdermal Patches Revenue Share by Country (2021-2032) Figure 62. Asia Buprenorphine Transdermal Patches Sales Share by Country (2021-2032) Figure 63. SAMEA Buprenorphine Transdermal Patches Revenue Share by Type (2021-2032) Figure 64. SAMEA Buprenorphine Transdermal Patches Sales Share by Type (2021-2032) Figure 65. SAMEA Buprenorphine Transdermal Patches Revenue Share by Application (2021-2032) Figure 66. SAMEA Buprenorphine Transdermal Patches Sales Share by Application (2021-2032) Figure 67. SAMEA Buprenorphine Transdermal Patches Revenue Share by Country (2021-2032) Figure 68. SAMEA Buprenorphine Transdermal Patches Sales Share by Country (2021-2032) Figure 69. Buprenorphine Transdermal Patches Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Buprenorphine Transdermal Patches Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 10mcg/h
  • 15 mcg/h
  • 20 mcg/h
  • 5mcg/h
  • 7.5mcg/h
Applications
  • Relieve Cancer Pain
  • Other
Companies covered
  • Luye Pharma
  • PurduePharma
  • Grunenthal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Buprenorphine Transdermal Patches Market by Type
  3. 1.2.1 Global Buprenorphine Transdermal Patches Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mcg/h
  5. 1.2.3 15 mcg/h
  6. 1.2.4 20 mcg/h
  7. 1.2.5 5mcg/h
  8. 1.2.6 7.5mcg/h
  9. 1.3 Buprenorphine Transdermal Patches Market by Application
  10. 1.3.1 Global Buprenorphine Transdermal Patches Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Relieve Cancer Pain
  12. 1.3.3 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Buprenorphine Transdermal Patches Market Dynamics
  1. 2.1 Buprenorphine Transdermal Patches Industry Trends
  2. 2.2 Buprenorphine Transdermal Patches Industry Drivers
  3. 2.3 Buprenorphine Transdermal Patches Industry Opportunities and Challenges
  4. 2.4 Buprenorphine Transdermal Patches Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Buprenorphine Transdermal Patches Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Buprenorphine Transdermal Patches Revenue by Region
  3. 3.2.1 Global Buprenorphine Transdermal Patches Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Buprenorphine Transdermal Patches Revenue by Region (2021-2026)
  5. 3.2.3 Global Buprenorphine Transdermal Patches Revenue by Region (2027-2032)
  6. 3.2.4 Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Buprenorphine Transdermal Patches Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Buprenorphine Transdermal Patches Sales by Region
  9. 3.4.1 Global Buprenorphine Transdermal Patches Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Buprenorphine Transdermal Patches Sales by Region (2021-2026)
  11. 3.4.3 Global Buprenorphine Transdermal Patches Sales by Region (2027-2032)
  12. 3.4.4 Global Buprenorphine Transdermal Patches Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Buprenorphine Transdermal Patches Revenue by Manufacturers
  2. 4.1.1 Global Buprenorphine Transdermal Patches Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Buprenorphine Transdermal Patches Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Buprenorphine Transdermal Patches Sales by Manufacturers
  6. 4.2.1 Global Buprenorphine Transdermal Patches Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Buprenorphine Transdermal Patches Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Buprenorphine Transdermal Patches Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Buprenorphine Transdermal Patches Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Buprenorphine Transdermal Patches Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Buprenorphine Transdermal Patches Manufacturers, Product Type & Application
  13. 4.7 Global Buprenorphine Transdermal Patches Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Buprenorphine Transdermal Patches Market CR5 and HHI
  16. 4.8.2 2025 Buprenorphine Transdermal Patches Tier 1, Tier 2, and Tier 3
5 Buprenorphine Transdermal Patches Market by Type
  1. 5.1 Global Buprenorphine Transdermal Patches Revenue by Type
  2. 5.1.1 Global Buprenorphine Transdermal Patches Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Buprenorphine Transdermal Patches Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Buprenorphine Transdermal Patches Sales by Type
  6. 5.2.1 Global Buprenorphine Transdermal Patches Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Buprenorphine Transdermal Patches Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Buprenorphine Transdermal Patches Sales Market Share by Type (2021-2032)
  9. 5.3 Global Buprenorphine Transdermal Patches Price by Type
6 Buprenorphine Transdermal Patches Market by Application
  1. 6.1 Global Buprenorphine Transdermal Patches Revenue by Application
  2. 6.1.1 Global Buprenorphine Transdermal Patches Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Buprenorphine Transdermal Patches Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Buprenorphine Transdermal Patches Sales by Application
  6. 6.2.1 Global Buprenorphine Transdermal Patches Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Buprenorphine Transdermal Patches Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Buprenorphine Transdermal Patches Sales Market Share by Application (2021-2032)
  9. 6.3 Global Buprenorphine Transdermal Patches Price by Application
7 Company Profiles
  1. 7.1 Luye Pharma
  2. 7.1.1 Luye Pharma Company Information
  3. 7.1.2 Luye Pharma Business Overview
  4. 7.1.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Luye Pharma Buprenorphine Transdermal Patches Product Portfolio
  6. 7.1.5 Luye Pharma Recent Developments
  7. 7.2 PurduePharma
  8. 7.2.1 PurduePharma Company Information
  9. 7.2.2 PurduePharma Business Overview
  10. 7.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 PurduePharma Buprenorphine Transdermal Patches Product Portfolio
  12. 7.2.5 PurduePharma Recent Developments
  13. 7.3 Grunenthal
  14. 7.3.1 Grunenthal Company Information
  15. 7.3.2 Grunenthal Business Overview
  16. 7.3.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grunenthal Buprenorphine Transdermal Patches Product Portfolio
  18. 7.3.5 Grunenthal Recent Developments
8 North America
  1. 8.1 North America Buprenorphine Transdermal Patches Market Size by Type
  2. 8.1.1 North America Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  3. 8.1.2 North America Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  4. 8.1.3 North America Buprenorphine Transdermal Patches Price by Type (2021-2032)
  5. 8.2 North America Buprenorphine Transdermal Patches Market Size by Application
  6. 8.2.1 North America Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  7. 8.2.2 North America Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  8. 8.2.3 North America Buprenorphine Transdermal Patches Price by Application (2021-2032)
  9. 8.3 North America Buprenorphine Transdermal Patches Market Size by Country
  10. 8.3.1 North America Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Buprenorphine Transdermal Patches Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Buprenorphine Transdermal Patches Market Size by Type
  2. 9.1.1 Europe Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  3. 9.1.2 Europe Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  4. 9.1.3 Europe Buprenorphine Transdermal Patches Price by Type (2021-2032)
  5. 9.2 Europe Buprenorphine Transdermal Patches Market Size by Application
  6. 9.2.1 Europe Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  7. 9.2.2 Europe Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  8. 9.2.3 Europe Buprenorphine Transdermal Patches Price by Application (2021-2032)
  9. 9.3 Europe Buprenorphine Transdermal Patches Market Size by Country
  10. 9.3.1 Europe Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Buprenorphine Transdermal Patches Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Buprenorphine Transdermal Patches Market Size by Type
  2. 10.1.1 China Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  3. 10.1.2 China Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  4. 10.1.3 China Buprenorphine Transdermal Patches Price by Type (2021-2032)
  5. 10.2 China Buprenorphine Transdermal Patches Market Size by Application
  6. 10.2.1 China Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  7. 10.2.2 China Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  8. 10.2.3 China Buprenorphine Transdermal Patches Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Buprenorphine Transdermal Patches Market Size by Type
  2. 11.1.1 Asia Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  3. 11.1.2 Asia Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  4. 11.1.3 Asia Buprenorphine Transdermal Patches Price by Type (2021-2032)
  5. 11.2 Asia Buprenorphine Transdermal Patches Market Size by Application
  6. 11.2.1 Asia Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  7. 11.2.2 Asia Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  8. 11.2.3 Asia Buprenorphine Transdermal Patches Price by Application (2021-2032)
  9. 11.3 Asia Buprenorphine Transdermal Patches Market Size by Country
  10. 11.3.1 Asia Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Buprenorphine Transdermal Patches Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Buprenorphine Transdermal Patches Market Size by Type
  2. 12.1.1 SAMEA Buprenorphine Transdermal Patches Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Buprenorphine Transdermal Patches Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Buprenorphine Transdermal Patches Price by Type (2021-2032)
  5. 12.2 SAMEA Buprenorphine Transdermal Patches Market Size by Application
  6. 12.2.1 SAMEA Buprenorphine Transdermal Patches Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Buprenorphine Transdermal Patches Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Buprenorphine Transdermal Patches Price by Application (2021-2032)
  9. 12.3 SAMEA Buprenorphine Transdermal Patches Market Size by Country
  10. 12.3.1 SAMEA Buprenorphine Transdermal Patches Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Buprenorphine Transdermal Patches Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Buprenorphine Transdermal Patches Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Buprenorphine Transdermal Patches Value Chain Analysis
  2. 13.1.1 Buprenorphine Transdermal Patches Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Buprenorphine Transdermal Patches Production Mode & Process
  6. 13.2 Buprenorphine Transdermal Patches Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Buprenorphine Transdermal Patches Distributors
  9. 13.2.3 Buprenorphine Transdermal Patches Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst